Skip to content

Zymeworks ZYME Common Stock

Common Stock at other companies

Amgen logo
AmgenAMGN
2.8B0.0%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$29K-3.3%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
200M0.0%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$816.53M+3.3%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$6K+20.0%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
500M0.0%

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.76B+125%
Enterprise value$1.53B+112%
P/S21.6×+13.2×

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's common stock?
Zymeworks (ZYME) reported common stock of 900M in Q1 2026.
How has Zymeworks's common stock changed year-over-year?
Zymeworks's common stock decreased by 0.0% year-over-year, from 900M to 900M.
What is the long-term trend for Zymeworks's common stock?
Over 4 years (2021 to 2025), Zymeworks's common stock has grown at a 5.0% compound annual growth rate (CAGR), from 741.1M to 900M.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).